2025Ebiomedicine116 : 105770
Somatic hypermutation shapes the viral escape profile of SARS-CoV-2 neutralising antibodies
Bruhn M, Obara M, Gonzalez-Hernandez M, Reineking W, Salam A, Mirolo M, Hinrichs I, Mergani A, Bartsch Y, Schambach A, Zimmer G, Baumgärtner W, Osterhaus A, Kalinke U
2024Genome Biology25 (1) : 228
Real-time identification of epistatic interactions in SARS-CoV-2 from large genome collections
Innocenti G, Obara M, Costa B, Jacobsen H, Katzmarzyk M, Cicin-Sain L, Kalinke U, Galardini M
2024Allergy : 10.1111/all.16241
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination
Buhre J, Pongracz T, Geisen U, Schubert M, Wang W, Nouta J, Obara M, Lehrian S, Rahmöller J, Petry J, Tran F, Schreiber S, Sümbül M, Berner D, Gerdes S, Schirmer J, Longardt A, Hoff P, Kalinke U, Ludwig R, Bartsch Y, Hoyer B, Wuhrer M, Ehlers M
2024European Journal of Immunology54 (7) : e2451056
Diversification of the VH3-53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS-CoV-2 virus variants
Bruhn M, Obara M, Salam A, Costa B, Ziegler A, Waltl I, Pavlou A, Hoffmann M, Graalmann T, Pöhlmann S, Schambach A, Kalinke U
2024The Journal of Infection88 (1) : 57-60
Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutation
Bruhn M, Obara M, Chiyyeadu A, Costa B, Salam A, Ziegler A, Waltl I, Pavlou A, Bonifacius A, Hoffmann M, Graalmann T, Pöhlmann S, Eiz-Vesper B, Schambach A, Kalinke U